Docteur Anne Yernaux, médecine générale
0837.168.693 · rovalta.com · 28/09/2026
Docteur Anne Yernaux, médecine générale
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODocteur Anne Yernaux, médecine générale is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0837.168.693
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 46,7 k € | -9.8% | 51,8 k € | -11.6% | 58,5 k € | -32.3% | 86,5 k € | +142% | 35,8 k € |
| EBITDA | 45,7 k € | -10.2% | 50,9 k € | -11.6% | 57,6 k € | -32.3% | 85 k € | +146% | 34,6 k € |
| Operating result | 33,6 k € | -13.1% | 38,7 k € | -14.7% | 45,3 k € | -43.7% | 80,5 k € | +355% | 17,7 k € |
| Net result | 17,6 k € | -27.0% | 24,2 k € | -14.8% | 28,4 k € | -56.9% | 65,8 k € | +678% | 8,5 k € |
| Balance sheet | |||||||||
| Equity | 189,4 k € | +10.3% | 171,7 k € | +15.8% | 148,4 k € | +29.5% | 114,6 k € | +131% | 49,6 k € |
| Total assets | 195,1 k € | +9.3% | 178,5 k € | +6.7% | 167,3 k € | +36.9% | 122,2 k € | +97.5% | 61,9 k € |
| Cash | 87,9 k € | +16.7% | 75,4 k € | +34.4% | 56,1 k € | +16.5% | 48,1 k € | +30.7% | 36,8 k € |
| Debts | 5,7 k € | -15.0% | 6,8 k € | -64.4% | 19 k € | +149% | 7,6 k € | -35.0% | 11,7 k € |
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ANNE YERNAUX | Directorsince 15/06/2011Managersince 01/01/2011ended |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/04/2025 | 01/06/2024 | 03/06/2023 | 06/06/2022 | 06/06/2021 | 14/06/2020 |
| General meeting | 26/03/2025 | 01/06/2024 | 03/06/2023 | 04/06/2022 | 05/06/2021 | 06/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 26/03/2025 | 23/04/2025 | French | |
| Micro model | 31/12/2023 | 01/06/2024 | 01/06/2024 | French | |
| Micro model | 31/12/2022 | 03/06/2023 | 03/06/2023 | French | |
| Micro model | 31/12/2021 | 04/06/2022 | 06/06/2022 | French | |
| Micro model | 31/12/2020 | 05/06/2021 | 06/06/2021 | French | |
| Micro model | 31/12/2019 | 06/06/2020 | 14/06/2020 | French | |
| Micro model | 31/12/2018 | 01/06/2019 | 09/06/2019 | French | |
| Abridged model | 31/12/2017 | 02/06/2018 | 03/06/2018 | French | |
| Abridged model | 31/12/2016 | 03/06/2017 | 06/06/2017 | French | |
| Abridged model | 31/12/2015 | 04/06/2016 | 06/06/2016 | French | |
| Abridged model | 31/12/2014 | 06/06/2015 | 06/06/2015 | French | |
| Abridged model | 31/12/2013 | 27/07/2014 | 29/07/2014 | French | |
| Abridged model | 31/12/2012 | 29/06/2013 | 10/07/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 27/07/2012 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ANNE YERNAUX | Directorsince 15/06/2011Managersince 01/01/2011ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| RUE DE WARNANT 40, 5537 Anhée | accounts 2021 → 2024 | Accounts 2024 · 2025-00078513 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DOCTEUR ANNE YERNAUX MEDECINE GENERALE | accounts 2021 → 2024 | Accounts 2024 · 2025-00078513 |
Events
- 2024Annual accounts 202417,6 k €↓
- 2023Annual accounts 202324,2 k €↓
- 2022Annual accounts 202228,4 k €↓
- 2021Annual accounts 202165,8 k €↑
- 2020Annual accounts 20208,5 k €↓
- 2019Annual accounts 201914,8 k €↑
- 2018Annual accounts 201810,9 k €↑
- 2017Annual accounts 20178,3 k €↑
- 2016Annual accounts 20161 k €↓
- 2015Annual accounts 20158,9 k €↓
- 2014Annual accounts 201413,8 k €↑
- 2013Annual accounts 2013-27,9 k €↓
- 2012Annual accounts 20121,2 k €
- 2011Annual accounts 2011